These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Thomas SR; Witting PK; Drummond GR Antioxid Redox Signal; 2008 Oct; 10(10):1713-65. PubMed ID: 18707220 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic interventions in endothelial dysfunction: endothelium as a target organ. Cooke JP Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-45-51. PubMed ID: 9422852 [TBL] [Abstract][Full Text] [Related]
30. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors]. Tschudi MR; Noll G; Lüscher TP Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890 [TBL] [Abstract][Full Text] [Related]
31. [Nitrous oxide and atherosclerosis. Pharmacotherapy of atherosclerosis and nitrous oxide]. Markov KhM Kardiologiia; 2010; 50(12):69-77. PubMed ID: 21591396 [No Abstract] [Full Text] [Related]
32. Role of endothelial dysfunction in atherosclerosis. Davignon J; Ganz P Circulation; 2004 Jun; 109(23 Suppl 1):III27-32. PubMed ID: 15198963 [TBL] [Abstract][Full Text] [Related]
33. [Endothelium and nitric oxide]. Garaliene V Medicina (Kaunas); 2008; 44(7):564-9. PubMed ID: 18695354 [TBL] [Abstract][Full Text] [Related]
34. Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum? Schmieder RE J Hypertens Suppl; 2006 Apr; 24(2):S31-5. PubMed ID: 16601559 [TBL] [Abstract][Full Text] [Related]
35. [Nephrology 2009]. Zidek W Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1316-8. PubMed ID: 19517322 [No Abstract] [Full Text] [Related]
36. Emerging therapies for cerebrovascular disorders. Fisher M; Davalos A Stroke; 2004 Feb; 35(2):367-9. PubMed ID: 14757882 [No Abstract] [Full Text] [Related]
37. Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Ceriello A Curr Opin Lipidol; 2006 Oct; 17(5):510-8. PubMed ID: 16960499 [TBL] [Abstract][Full Text] [Related]
38. Does reversal of oxidative stress and inflammation provide vascular protection? Koh KK; Oh PC; Quon MJ Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298 [TBL] [Abstract][Full Text] [Related]
39. [Pharmacological therapy of age-related macular degeneration based on etiopathogenesis]. Fischer T Orv Hetil; 2015 Nov; 156(46):1847-58. PubMed ID: 26548469 [TBL] [Abstract][Full Text] [Related]
40. Endothelial function and dysfunction in heart failure. Ferrari R; Bachetti T; Agnoletti L; Comini L; Curello S Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]